Watts Ryan J.
Known title: President and CEOCIK: 0001724310
Associated companies
Transaction History
| DNLI | ▼ Sell | Gift | 32,220 | $0 | 8/12/2026 | View on chart |
| DNLI | ▼ Sell | Open Market | 35,198 | $581K | 1/6/2026 | View on chart |
| DNLI | ▲ Buy | Grant | 78,960 | $0 | 1/3/2026 | View on chart |
| DNLI | ▼ Sell | Gift | 50,000 | $0 | 9/3/2025 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 455,282 | $310K | 7/9/2025 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 40,000 | $211K | 7/9/2025 | View on chart |
| DNLI | ▼ Sell | Open Market | 495,282 | $7.4M | 7/9/2025 | View on chart |
| DNLI | ▼ Sell | Open Market | 7,650 | $159K | 1/7/2025 | View on chart |
| DNLI | ▼ Sell | Open Market | 29,266 | $592K | 1/6/2025 | View on chart |
| DNLI | ▲ Buy | Grant | 54,180 | $0 | 1/3/2025 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 40,000 | $27K | 10/18/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 40,000 | $1.1M | 10/18/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,260 | $54K | 8/20/2024 | View on chart |
| DNLI | ▼ Sell | Gift | 40,000 | $0 | 3/29/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,589 | $166K | 2/13/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 7,818 | $155K | 1/9/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 17,483 | $340K | 1/5/2024 | View on chart |
| DNLI | ▲ Buy | Grant | 89,520 | $0 | 1/3/2024 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,309 | $52K | 8/21/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 2,526 | $2K | 8/10/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,526 | $63K | 8/10/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 50,000 | $34K | 6/16/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 50,000 | $1.6M | 6/16/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 24,800 | $17K | 4/21/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 24,800 | $624K | 4/21/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 200 | $5K | 4/20/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 200 | $136 | 4/20/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 8,815 | $265K | 2/13/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 25,000 | $752K | 2/13/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 25,000 | $17K | 2/13/2023 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 25,000 | $17K | 2/10/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 25,000 | $728K | 2/10/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 3,433 | $105K | 2/9/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 4,800 | $137K | 1/5/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 5,029 | $144K | 1/4/2023 | View on chart |
| DNLI | ▲ Buy | Grant | 82,240 | $0 | 1/3/2023 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,404 | $80K | 8/19/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,491 | $330K | 2/11/2022 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 6,118 | $59K | 2/10/2022 | View on chart |
| DNLI | ▲ Buy | Option Exercise | 64,631 | $341K | 2/10/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 2,719 | $102K | 2/9/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 5,007 | $224K | 1/5/2022 | View on chart |
| DNLI | ▲ Buy | Grant | 62,000 | $0 | 1/3/2022 | View on chart |
| DNLI | ▼ Sell | Open Market | 8,516 | $378K | 12/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 9,012 | $408K | 12/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 805 | $37K | 12/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 1,659 | $81K | 11/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 16,674 | $832K | 11/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 3,304 | $163K | 10/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 10,782 | $544K | 10/1/2021 | View on chart |
| DNLI | ▼ Sell | Open Market | 4,247 | $217K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Denali Therapeutics Shares Test Fair Value Amid Pullback
Denali Therapeutics shares have pulled back, testing the $19.37 support level. The 14‑day RSI sits at 30, indicating a possible oversold condition, while the support_reject signal suggests the level may hold. Analysts average a target of $36.06, with a range of $27 to $42, well above the current price and the 52‑week low of $13.75. The pullback could be seen as a chance to assess fair value.
Denali Therapeutics Shares Test Fair Value Amid Pullback. Denali Therapeutics shares have pulled back, testing the $19.37 support level. The 14‑day RSI sits at 30, indicating a possible oversold condition, while the support_reject signal suggests the level may hold. Analysts average a target of $36.06, with a range of $27 to $42, well above the current price and the 52‑week low of $13.75. The pullback could be seen as a chance to assess fair value.